OSE Immunotherapeutics
OSE.PA
#10411
Rank
ยฃ30.29 M
Marketcap
ยฃ1.18
Share price
-7.17%
Change (1 day)
-74.91%
Change (1 year)

Revenue for OSE Immunotherapeutics (OSE.PA)

Revenue in 2025: ยฃ2.35 Million

According to OSE Immunotherapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ2.35 Million. In 2025 the company made a revenue of ยฃ2.35 Million a decrease over the revenue in the year 2024 that were of ยฃ55.58 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for OSE Immunotherapeutics from 2012 to 2025

Annual revenue

Year Revenue Change
2025ยฃ2.35 M-95.77%
2024ยฃ55.58 M2853.66%
2023ยฃ1.88 M-87.46%
2022ยฃ15 M-34.1%
2021ยฃ22.77 M132.49%
2020ยฃ9.79 M-55.92%
2019ยฃ22.22 M3.91%
2018ยฃ21.38 M248.96%
2017ยฃ6.12 M1890.13%
2016ยฃ0.3 M9111.17%
2015ยฃ0 M
2014N/A
2013N/A
2012N/A